FOSL1 and neoplasm: In prostate cancer, the expression of miRNA-195-5p decreases abnormally, and its ability to suppress the expression of FOSL1 decreases, which leads to an increase in the content of FOSL1 and promotes invasion and metastasis of the tumor.